INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $359,000 | -73.4% | 316,146 | -47.3% | 0.00% | -50.0% |
| Q4 2021 | $1,349,000 | +2308.9% | 600,239 | +3597.0% | 0.00% | – |
| Q3 2021 | $56,000 | -87.2% | 16,236 | -88.9% | 0.00% | -100.0% |
| Q2 2021 | $438,000 | -80.4% | 146,742 | -78.8% | 0.00% | -80.0% |
| Q1 2021 | $2,236,000 | +3094.3% | 691,892 | +1759.3% | 0.01% | – |
| Q1 2019 | $70,000 | +40.0% | 37,212 | -12.8% | 0.00% | -100.0% |
| Q4 2018 | $50,000 | -80.8% | 42,671 | -14.0% | 0.00% | -66.7% |
| Q1 2016 | $261,000 | +0.8% | 49,589 | +223.4% | 0.00% | 0.0% |
| Q4 2014 | $259,000 | -0.8% | 15,336 | -21.2% | 0.00% | -25.0% |
| Q3 2014 | $261,000 | – | 19,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |